Who owns OMEROS CORP (OME)? Elite investor 13F holders

3 tracked elite investors reported holding OMEROS CORP as of 2026-09-30, including D.E. Shaw, Ancora Advisors / Ancora Holdings, Polen Capital Management. Who bought, trimmed or exited each quarter, with links to the original SEC 13F filings.

3 tracked investors currently reported holding · Latest report period: 2026-09-30 · Health Care · Pharmaceuticals, Biotechnology & Life Sciences

Reported holders and securities, including exits (up to 20)

Reported holders and securities, including exits (up to 20)
InvestorSecurityInstrumentReport periodFiledValueQuantityUnitsChangeSource
D.E. ShawOMEROS CORPSHARE2026-09-302026-11-16 00:00:0040360405.00 USD12380000.000000PrincipalreduceOriginal filing
Rubric CapitalOMEROS CORPSHARE2026-09-302026-11-16 00:00:000.00 USD0.000000SharesexitedOriginal filing
Ancora Advisors / Ancora HoldingsOMEROS CORPSHARE2026-06-302026-08-14 00:00:001604812.00 USD168750.000000SharesaddOriginal filing
Polen Capital ManagementOMEROS CORPSHARE2026-09-302026-11-13 00:00:00595000.00 USD31250.000000SharesbuyOriginal filing
D.E. ShawOMEROS CORPSHARE2026-09-302026-11-16 00:00:00250243.00 USD13143.000000SharesbuyOriginal filing

Public disclosures can be delayed, incomplete, or amended. Report period describes a position date; transaction date describes a reported transaction; filed describes submission. A recent filing or page update does not establish a current holding. A dash means unavailable or not comparable, not zero.

This public summary shows the default reporting scope. Enable JavaScript for interactive filters, charts, and additional rows.

How to read the data · Disclaimer

Read as Markdown